We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$14.6B
AUM Growth
+$1.24B
Cap. Flow
+$998M
Cap. Flow %
6.84%
Top 10 Hldgs %
15.27%
Holding
2,202
New
241
Increased
1,177
Reduced
603
Closed
133

Sector Composition

Rank Sector Weight
1 Energy 9.2%
2 Healthcare 8.03%
3 Technology 7.82%
4 Financials 7.64%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTV icon
226
Vanguard Morningstar Value ETF
VTV
$191B
$14.2M 0.1%
182,187
+5,423
+3% +$411K
DAR icon
227
Darling Ingredients
DAR
$9.44B
$14.2M 0.1%
707,611
+20,413
+3% +$409K
MET icon
228
MetLife
MET
$62.1B
$14M 0.1%
298,416
+4,556
+2% +$209K
ACH
229
Accendra Health
ACH
$214M
$14M 0.1%
398,965
+26,631
+7% +$940K
TAP icon
230
Molson Coors Class B
TAP
$8.09B
$14M 0.1%
237,401
+10,644
+5% +$595K
CAH icon
231
Cardinal Health
CAH
$55.4B
$13.9M 0.1%
198,951
-25,772
-11% -$1.79M
TPR icon
232
Tapestry
TPR
$32.8B
$13.7M 0.09%
276,518
-3,000
-1% -$149K
CA
233
DELISTED
CA, Inc.
CA
$13.7M 0.09%
441,334
+25,670
+6% +$837K
IVV icon
234
iShares Core S&P 500 ETF
IVV
$902B
$13.6M 0.09%
72,431
+638
+0.9% +$118K
XLF icon
235
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$13.6M 0.09%
693,279
+294,283
+74% +$5.62M
VV icon
236
Vanguard Morningstar Large-Cap ETF
VV
$54.3B
$13.6M 0.09%
157,786
+4,169
+3% +$352K
IJK icon
237
iShares S&P Mid-Cap 400 Growth ETF
IJK
$11.2B
$13.5M 0.09%
354,040
+24,084
+7% +$907K
TRN icon
238
Trinity Industries
TRN
$2.38B
$13.5M 0.09%
521,411
-165,011
-24% -$3.81M
ZD icon
239
Ziff Davis
ZD
$1.98B
$13.5M 0.09%
310,354
-687
-0.2% -$29K
VWO icon
240
Vanguard FTSE Emerging Markets ETF
VWO
$124B
$13.3M 0.09%
326,561
+2,533
+0.8% +$98.2K
HBI
241
DELISTED
Hanesbrands
HBI
$13.2M 0.09%
692,668
+22,564
+3% +$405K
AIG icon
242
American International
AIG
$41.3B
$13.2M 0.09%
264,667
+37,405
+16% +$1.86M
CHKP icon
243
Check Point Software Technologies
CHKP
$13.1B
$13.2M 0.09%
195,258
+100,109
+105% +$6.62M
EWRI
244
DELISTED
GUGGENHEIM RUSSELL 1000 EQUAL WEIGHT ETF
EWRI
$13.2M 0.09%
273,646
+4,407
+2% +$207K
DVA icon
245
DaVita
DVA
$11.7B
$13.1M 0.09%
190,645
+61,951
+48% +$4.12M
IRM icon
246
Iron Mountain
IRM
$36.1B
$13.1M 0.09%
513,861
+29,429
+6% +$753K
PLL
247
DELISTED
PALL CORP
PLL
$13.1M 0.09%
146,212
+17,899
+14% +$1.52M
GS icon
248
Goldman Sachs
GS
$303B
$13M 0.09%
79,201
+7,402
+10% +$1.24M
CLH icon
249
Clean Harbors
CLH
$16.3B
$13M 0.09%
236,526
+56,180
+31% +$3.06M
GEO icon
250
The GEO Group
GEO
$4.04B
$12.9M 0.09%
602,301
+32,490
+6% +$703K

Similar funds

Raymond James & Associates's Q1 2014 Portfolio in Review

As of Q1 2014, Raymond James & Associates held 2,202 positions worth $14.6B, up 9.3% from $13.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Raymond James & Associates deployed $998M of net new capital in Q1 2014, opening 241 new positions and adding to 1,177 existing holdings. Its largest new stake was Edgewell Personal Care: 199,912 shares worth $14.9M.

By sector, the portfolio is most concentrated in Energy at 9.2% of assets, down from 9.4% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vodafone, an estimated $33.9M trimmed.

  • Raymond James & Associates's largest Q1 2014 buy was Edgewell Personal Care: 199,912 shares worth $14.9M.
  • Raymond James & Associates added most to Verizon in Q1 2014, an estimated $31.6M increase.
  • Raymond James & Associates's biggest Q1 2014 reduction was Vodafone, cutting an estimated $33.9M.
  • Raymond James & Associates fully exited Nu Skin in Q1 2014, selling an estimated $5.53M.
  • Raymond James & Associates's ten largest holdings make up 15% of its $14.6B portfolio in Q1 2014.
  • Raymond James & Associates opened 241 new positions and closed 133 in Q1 2014.
  • Raymond James & Associates's portfolio value rose 9.3% quarter-over-quarter to $14.6B.

Based on Raymond James & Associates's 13F filing for Q1 2014, filed 13 May 2014.